发明名称 Formulations and methods for treating oral inflammation, injury, or pain
摘要 The present invention generally relates to formulations and methods for treating oral inflammation, oral injury and/or oral pain by applying hydrogel, viscous liquid, or other formulation to the oral cavity. Wet formulations comprise a hydrophilic polymer selected from the group consisting of pyrrolidones, hyaluronic acid and salts thereof, alginic acid and salts thereof, and carrageenans and salts thereof; calcium salts or ions, phosphate salts or ions, and water as well as other optional components. Dry formulations such as powders are also contemplated.
申请公布号 US9433644(B2) 申请公布日期 2016.09.06
申请号 US201414340447 申请日期 2014.07.24
申请人 Rutgilli Pharmaceuticals, LLC 发明人 Kobus Edward D.;Weldon Bartholomew
分类号 A61F13/02;A61K33/42;A61K33/14;A61Q11/00;A61K33/00;A61K47/02;A61K9/00;A61K47/32;A61K47/36;A61K47/38 主分类号 A61F13/02
代理机构 Neal, Gerber & Eisenberg LLP 代理人 Neal, Gerber & Eisenberg LLP
主权项 1. A dry formulation adapted for reconstituting with water to form a liquid formulation for treating oral injury, oral inflammation and/or oral pain, the dry formulation comprising: one or more hydrophilic polymers, at least one of which is selected from the group consisting of: pyrrolidones,hyaluronic acids and salts thereof;alginic acids and salts thereof;carrageenans and salts thereof;celluloses;dextrins;and mixtures thereof, wherein said hydrophilic polymers are present in an amount between 4% to 85%, based on the total weight of the dry formulation; from 2.5% to 7% by weight, based on the total weight of the dry formulation, of one or more calcium salts; from 0.4% to 1.2% by weight, based on the total weight of the dry formulation, of one or more phosphate salts; and sodium chloride.
地址 Chicago IL US